Gastrointestinal Cancer News

Approximately one in 12 patients with a common primary tumor were diagnosed with a second primary malignancy between 1992 and 2008, according to results of a SEER analysis.

Researchers from Taiwan developed a temporal mutation profile that discerned which patients with hepatitis B virus are more likely to develop hepatocellular carcinoma within 5 years, according to recent findings published in Hepatology.

Higher intake of omega 3 fatty acids from oily fish after a diagnosis of colorectal cancer was associated with a reduced risk for cancer-specific mortality, according to the results of a prospective study published in Gut.

Sorafenib was associated with a reduction in immune-suppressive phenotypes in patients with hepatocellular carcinoma, according to recent findings published in JCI Insight.

Delirium occurs frequently but appears underdiagnosed in patients with advanced cancer who presented in the ED, according to the results of a randomized observational study.

Strong evidence exists that alcohol consumption causes cancer at seven specific sites in the body, according to a paper published in Addiction.

Women have a 37% chance of developing invasive cancer during their lifetime, and a 19% chance of dying of cancer, according to American Cancer Society statistics.

Top-line data from a randomized phase 3 study suggest the drug ABP 980 could be an effective biosimilar to trastuzumab for the treatment of patients with HER-2–positive early breast cancer, according to a press release from the agent’s manufacturers.

The American Society for Radiation Oncology announced the recipients of the society’s gold medal, the highest honor bestowed upon society members.

Men have a 42% chance of developing invasive cancer during their lifetime, and a nearly 23% chance of dying of cancer, according to American Cancer Society statistics.